-
AI accelerates Parkinson's disease drug design tenfold, identifying small molecules that prevent protein aggregation characteristic of the disease
According to the official website of the University of Cambridge in the UK, researchers at the university have greatly accelerated the development of treatments for Parkinson's disease through artificial intelligence technology. The researchers designed and used an AI-based strategy to identify small molecules that prevent the aggregation of alpha-synuclein (IT Home Note: a characteristic protein of Parkinson's disease). This is also a way to find potential treatments for Parkinson's disease. The team used machine learning technology to quickly screen a chemical library containing millions of entries to identify small molecules that bind to amyloid aggregates and prevent their proliferation, and ultimately identified 5 highly effective compounds...- 1.1k
❯
Search
Scan to open current page
Top
Checking in, please wait
Click for today's check-in bonus!
You have earned {{mission.data.mission.credit}} points today!
My Coupons
-
¥CouponsLimitation of useExpired and UnavailableLimitation of use
before
Limitation of usePermanently validCoupon ID:×Available for the following products: Available for the following products categories: Unrestricted use:Available for all products and product types
No coupons available!
Unverify
Daily tasks completed: